Average Co-Inventor Count = 14.90
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (22 from 169 patents)
22 patents:
1. 12129237 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
2. 11325890 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
3. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
4. 10919865 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
5. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
6. 10266500 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
7. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
8. 10040770 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
9. 9795607 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
10. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
11. 9701643 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
12. 9428509 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
13. 9346812 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
14. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
15. 9139534 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith